FY25: Solid execution with margin expansion, but cautious FY26 guidance
04/02/26 -"The FY25 performance was in line with expectations, with 7.6% revenue growth and 170bps margin expansion driven by BPS strength, improved mix, and scale benefits. The order book was also strong for ..."
Pages
64
Language
English
Published on
04/02/26
You may also be interested by these reports :
16/02/26
The target price benefits from higher earnings expectations, along with a 20% premium added to the peer-based valuation. This reflects the firm’s ...
13/02/26
Dominant positioning for critical medical equipment (such as ventilators and heart-lung machines) in hospitals’ operating rooms, with two-thirds ...
12/02/26
CZM reported weak Q1 results, with challenges in both ophthalmology and microsurgery. Profitability declined significantly due to FX headwinds, an ...
11/02/26
4Q sales increased 12.1% YoY (18.4% at constant currency) to €7.6bn, mainly driven by strong growth in AI glasses. However, this category continues ...